The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Efficacy and tolerability of sunitinib in patients with advanced thyroid cancer out of a trial: A Spanish multicenter cohort.
E. Grande Pulido
No relevant relationships to disclose
B. Castelo
No relevant relationships to disclose
P. J. Fonseca
No relevant relationships to disclose
L. Iglesias
No relevant relationships to disclose
M. A. Vaz
No relevant relationships to disclose
J. Barriuso
No relevant relationships to disclose
M. Izquierdo
No relevant relationships to disclose
S. Guadalix
No relevant relationships to disclose
J. J. Diez
No relevant relationships to disclose
J. M. SepĂșlveda
No relevant relationships to disclose